Compare · GMED vs SIBN
GMED vs SIBN
Side-by-side comparison of Globus Medical Inc. (GMED) and SI-BONE Inc. (SIBN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GMED and SIBN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- GMED is the larger of the two at $9.09B, about 8.5x SIBN ($1.07B).
- SIBN has been more active in the news (18 items in the past 4 weeks vs 9 for GMED).
- GMED has more recent analyst coverage (25 ratings vs 12 for SIBN).
- Company
- Globus Medical Inc.
- SI-BONE Inc.
- Price
- -
- -
- Market cap
- $9.09B
- $1.07B
- 1M return
- -12.76%
- -
- 1Y return
- -16.54%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2012
- 2018
- News (4w)
- 9
- 18
- Recent ratings
- 25
- 12
Globus Medical Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
SI-BONE Inc.
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Latest GMED
- Director Tobin James R exercised 41,666 shares at a strike of $56.30 and sold $3,131,547 worth of shares (41,666 units at $75.16) (SEC Form 4)
- SEC Form 144 filed by Globus Medical Inc.
- Globus Medical to Participate in Jefferies Global Healthcare Conference
- Globus Medical downgraded by BMO Capital Markets with a new price target
- Director Rhoads Ann D sold $425,000 worth of shares (5,000 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 35,384 units (SEC Form 4)
- SEC Form 10-Q filed by Globus Medical Inc.
- Globus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
- Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Latest SIBN
- SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026
- Chief Executive Officer Laura Francis sold $392,877 worth of shares (16,854 units at $23.31) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 351,275 units (SEC Form 4) (for tax liability)
- Chief Legal Officer Michael A. Pisetsky sold $86,858 worth of shares (3,725 units at $23.32), decreasing direct ownership by 2% to 160,719 units (SEC Form 4) to satisfy withholding tax
- Chief Op & Financial Officer Anshul Maheshwari sold $148,574 worth of shares (6,380 units at $23.29) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 204,870 units (SEC Form 4) (for tax liability)
- SEC Form 144 filed by SI-BONE Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.
- Amendment: SVP, Ops & Adm/Chief Legal Ofr Pisetsky Michael A. exercised 12,349 shares at a strike of $22.00 and sold $901,844 worth of shares (36,241 units at $24.88) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Executive Officer Francis Laura sold $1,897,642 worth of shares (75,000 units at $25.30) as part of a pre-agreed trading plan (SEC Form 4)
- SVP, Ops & Adm/Chief Legal Ofr Pisetsky Michael A. sold $898,802 worth of shares (36,241 units at $24.80) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Op & Financial Officer Maheshwari Anshul sold $81,175 worth of shares (3,247 units at $25.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 211,250 units (SEC Form 4)